• Home
  • Company
    • Company Profile
    • Toronto Location
    • Business Strategy
    • Mission Statement
    • Company Facilities
    • Confidentiality Agreement
    • Privacy Statement
    • Accessibility
  • Services
    • cGMP Sterile Filling
      • Aseptic Filling Vials – Sterile Liquid Injectables
      • Lyophilization Services
      • Sterile Lyophilized Vials
      • Sterile Powder Filling in Vials
      • Capmatic Patriot® Sterile Vial Filling
      • Steriles Made Simple℠
    • cGMP API Manufacturing
      • cGMP Sterile API Manufacturing
      • cGMP API Customers
    • API Process Development
    • Formulation Development
      • Liposomal Formulations
      • Sterile Formulation Development
    • Custom Synthesis & Fine Chemical
    • Flow Chemistry
    • Conjugation
    • Custom Peptide Synthesis
    • GMP Oligonucleotide Fill
    • Microbiology Services
      • Disinfectant Qualification
    • Contract Analytical Services
      • Analytical Development
      • Structure Elucidation of Impurities
      • Accelerated Stability
      • SEC-MALS
      • ICP-MS Elemental Analysis
      • UPLC Analysis
      • Extractables & Leachables
    • Contract Research
    • Medicinal Chemistry
    • Polymorphic Screening
    • Project Management
  • Products
    • Building Blocks
    • Drugs & Metabolites
    • Glitazones
    • Coelenterazines
    • GMP APIs, Excipients & Diagnostic Reagents
    • Heterocycles
    • Labelled Compounds
    • Natural Compounds
    • Metabolites & Impurities
    • Nucleic Acids
    • Organometallics
    • Peptides
    • Cannabinoids
    • Controlled Drugs
  • Careers
    • Job Postings
      • Finance Admin
      • Engineering & Maintenance
      • Research & Development
      • Manufacturing & Operations
      • Sales, Marketing & PM
      • QC, QA & Microbiology
    • Culture
    • Benefits
    • Employee Testimonials
  • Resources
    • Schedule Virtual Meeting
    • Conferences
    • Whitepapers
    • Peter's Picks
    • Articles
    • Industry
    • QA Regulatory Affairs
    • Government
  • News
  • Contact
Dalton Technical Reports

Dalton Whitepapers

Whitepaper: Extractables & Leachables - 2021

Top 7 Considerations When Conducting
Extractable & Leachable Studies
- 2021

Whitepaper: Orphan Drugs - 2021

Whitepaper: Pharmaceutical Psychedelics - 2021

Whitepaper: Health Canada Guidelines,
for GMP of API
- 2021

Whitepaper: FDA Guidelines,
for GMP of API
- 2021

Whitepaper: API & Dosage Form Development
- 2021

Whitepaper: FDA Investigational New Drug
Application
- 2021

Whitepaper: Global Expedited Review
Programs & Incentives
- 2021

Whitepaper: Market Application & Incentives
for Drug Commercialization
- 2021

Whitepaper: Global Approval Process for new
Pharmaceutical Products and Timelines
for Market Applications
- 2021

Whitepaper: Regulatory Roadblocks &
Expeditions for Global Clinical Trials
- 2021

Whitepaper: Top 7 Covid-19 Impacts on
Global Regulatory Practices in
Biotech Industries
- 2021

Whitepaper: Top 10 Revisions in the
EC Annex 1 (2020): A Harmonization
of Global Sterile Filling
- 2021

Whitepaper: Top 12 Recent Global API
Regulatory Developments
- 2022

Whitepaper: 5 Steps for Pharmaceutical
Funding & Reimbursement in Canada
and the impacts of Covid-19
- 2021

Discover     Develop     Manufacture
  • Home
  • Company
  • Services
  • Products
  • Careers
  • Resources
  • News
  • Contact

Privacy Statement

© Dalton Pharma Services - All Rights Reserved.
349 Wildcat Rd. Toronto, ON M3J 2S3 CANADA   Phone: (416) 661-2102 or (800) 567-5060